# Effects of Vadadustat on Anemia, Quality of Life, and Inflammation in Dialysis Patients

> **NCT07537816** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Mackay Memorial Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Renal Anemia

## Interventions

- **DRUG:** Vadadustat

## Key facts

- **NCT ID:** NCT07537816
- **Lead sponsor:** Mackay Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-15
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-10-15
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07537816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07537816, "Effects of Vadadustat on Anemia, Quality of Life, and Inflammation in Dialysis Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07537816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*